CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pühringer, F. K.
Right arrow Articles by Keller, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pühringer, F. K.
Right arrow Articles by Keller, C.
Related Collections
Right arrow General Anesthesia
Canadian Journal of Anesthesia 47:347-349 (2000)
© Canadian Anesthesiologists' Society, 2000

Brief Report

Smoking does not alter the dose-requirements and the pharmacodynamics of rocuronium

Friedrich K. Pühringer, MD, Philipp Keller, CM, Alexander Löckinger, MD, Axel Kleinsasser, MD, Annkatrin Scheller, CM, Claus Raedler, CM and Christian Keller, MD

From the Department of Anaesthesia and General Intensive Care Medicine, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.

Address correspondence to: Univ. Prof. Dr. Friedrich K. Pühringer. Phone: 43-512-504-4319; Fax: 43-512-504-2450; E-mail: friedrich.puehringer{at}uibk.ac.at

Purpose: Controversial data about the effect of smoking on the dose-requirements and the pharamcodynamics of rocuronium have been reported recently. This study was conducted to evaluate the dose-requirements and the pharmacodynamics of rocuronium in smokers using target controlled infusion.

Methods: The dose-requirements of rocuronium for 60 min relaxation, using target controlled infusion, given under intravenous anaesthesia with propofol, fentanyl and nitrous oxide was studied in 37 smokers and 37 non-smokers. Initially 450 µg•kg–1 rocuronium were administered, neuromuscular effects were quantified by recording the single twitch response of the adductor pollicis muscle after ulnar nerve stimulation using a force transducer, and the neuromuscular block was kept at 80% by target controlled infusion throughout the procedure.

Results: The dose-requirements for one hour relaxation were 867 ± 116 µg•kg–1•hr–1 for smokers (S) and 839 ± 149 µg•kg–1•hr–1 for non-smokers (NS). The duration to 10% and the spontaneous recovery from 25% to 75% of the control twitch response also showed no differences between S (17.2 ± 3.4 min, 10.6 ± 0.9 min ) and NS (18.9 ± 4.3 min, 10.9 ± 3.2 min), as well as maximum block, onset time and infusion rate.

Conclusion: Smoking does not alter the dose-requirements for rocuronium and no effects on the onset time, degree of block, time to maximum block, duration 10% and spontaneous recovery index were observed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Canadian Anesthesiologists' Society.